CD82 and renal cell carcinoma: When CD82 was interfered or overexpressed artificially in our study, the changes of p-Smad2/3 expressions were consistent with TGF-β1, which revealed that CD82 can exactly play a negative regulation role of TGF-β1/Smad signaling in RCC cell line.